A comprehensive view of Blood Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca ends collaboration with FibroGen on oral anemia drug roxadustat following FDA rejection, returns rights to the drug in the US and several other countries; AstraZeneca retains interest in China and South Korea where the drug has been approved

Bristol-Myers Squibb receives EMA's positive opinion on anemia therapy, bolsters collaborative health initiatives, and continues technological advancement in disease treatment

CHMP recommends approval of Bristol Myers' Reblozyl for adult patients with transfusion-dependent anemia due to myelodysplastic syndromes; if approved by the European Commission, it would represent the fourth authorized indication for Reblozyl in the EU

CHMP recommends approval of Janssen's CARVYKTI cilta-cel for earlier treatment of relapsed and refractory multiple myeloma; this marks the first time a CAR-T therapy has received a positive CHMP opinion for this patient population post first relapse

Roche Expands Hemostasis Testing Panel with Launch of Three New FXa Inhibitor Assays, Enhancing Patient Management in Anticoagulant Therapy

Ask us about our Bioeconomy market view

Trending Chart

Interactive chart with headline count